rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
5
|
pubmed:dateCreated |
2001-1-17
|
pubmed:abstractText |
Despite the use of radical locoregional therapeutic methods and although conventional methods of diagnosis give no indication of metastases at the time of operation, distant metastases develop in approximately 50% of carcinoma patients within 5 years. While local relapses after the R0 resection of solid tumors are mainly a matter of concern for the surgeon, distant metastases can be traced back to the systemic dissemination of tumor cells at the time of operation.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
1435-2443
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
385
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
337-43
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:11026705-Aged,
pubmed-meshheading:11026705-Antibodies, Monoclonal,
pubmed-meshheading:11026705-Bone Marrow,
pubmed-meshheading:11026705-Carcinoma,
pubmed-meshheading:11026705-Colonic Neoplasms,
pubmed-meshheading:11026705-Female,
pubmed-meshheading:11026705-Follow-Up Studies,
pubmed-meshheading:11026705-Humans,
pubmed-meshheading:11026705-Immunohistochemistry,
pubmed-meshheading:11026705-Keratins,
pubmed-meshheading:11026705-Male,
pubmed-meshheading:11026705-Middle Aged,
pubmed-meshheading:11026705-Neoplasm Seeding,
pubmed-meshheading:11026705-Prognosis,
pubmed-meshheading:11026705-Prospective Studies,
pubmed-meshheading:11026705-Survival Rate,
pubmed-meshheading:11026705-Tumor Markers, Biological
|
pubmed:year |
2000
|
pubmed:articleTitle |
Cytokeratin-positive cells in bone marrow in comparison with other prognostic factors in colon carcinoma.
|
pubmed:affiliation |
Chirurgische Klinik I, Universität Leipzig, Germany. leinungs@medizin.uni-leipzig.de
|
pubmed:publicationType |
Journal Article
|